Minukhin V V, Tsyganenko A Ia
Zh Mikrobiol Epidemiol Immunobiol. 1986 Sep(9):90-2.
An experimental study was made with a view to finding out the possible bacteriological advantages of the combined use of tobramycin (Tb) and P. aeruginosa corpuscular polyvalent vaccine (PaCPV) or P. aeruginosa hyperimmune plasma (PaHIP) in burn sepsis caused by P. aeruginosa. The use of the median therapeutic dose of Tb (2.5 mg/kg body weight per day), alone or in combination with immunopreparations, ensured the survival rate of the animals equal to 100%. The contamination of the body with P. aeruginosa after treatment with Tb and PaHIP or PaCPV was lower than after the administration of Tb alone, this phenomenon becoming manifest starting from day 5 of observation in the first case and from day 10 in the second case. The combined use of Tb and immunopreparations (PaCPV or PaHIP) in acute P. aeruginosa infection proved to be more effective than treatment with Tb alone.
为了探究妥布霉素(Tb)与铜绿假单胞菌多价菌苗(PaCPV)或铜绿假单胞菌高免疫血浆(PaHIP)联合使用在铜绿假单胞菌所致烧伤脓毒症中可能存在的细菌学优势,开展了一项实验研究。使用妥布霉素的中位治疗剂量(每天2.5毫克/千克体重),单独使用或与免疫制剂联合使用,可确保动物存活率达到100%。在用妥布霉素和PaHIP或PaCPV治疗后,动物身体被铜绿假单胞菌污染的程度低于单独使用妥布霉素后的情况,这种现象在第一种情况下从观察第5天开始显现,在第二种情况下从第10天开始显现。在急性铜绿假单胞菌感染中,妥布霉素与免疫制剂(PaCPV或PaHIP)联合使用被证明比单独使用妥布霉素治疗更有效。